Diabetic Nephropathy Market 2034: Growing Role of GLP-1 Therapies...

σε πρόσθεσε στο άλλο

2026-10-05 10:10:09 -

Diabetic Nephropathy Market 2034: Growing Role of GLP-1 Therapies in Kidney Disease

GLP-1 receptor agonists are gaining greater attention as diabetes care increasingly incorporates cardiovascular and renal outcomes. Current guidance recognizes agents with demonstrated benefits for people with type 2 diabetes and CKD. Continued clinical research and broader utilization could further diversify treatment options within diabetic nephropathy care. The Diabetic Nephropathy Market is...

0 Σχόλια 0 Μοιράστηκε 7 Views 0 Προεπισκόπηση